It was a mixed year in 2022 for venture capital as fundraising hit an all-time high, whereas deal activity slowed and exits capitulated. The start of this year should see these trends move in the same direction as appetite for fast-growing startups wanes and investor focus shifts to profitability and ... READ MORE >
venture capital
Venture capital activity slows even as deal counts and fundraising hit records
Venture capital deal and exit activity for the first nine months of the year were well below the explosive pace set last year as various headwinds set in during the third quarter to cool off the blazing trends that had prevailed since the second quarter of 2020. Deal activity through September totaled ... READ MORE >
Hybrid funds emerge as a growing force in venture capital: Spring 2022 outlook
At a glance Record fundraising from traditional investors gave U.S. venture capital funds the dry powder needed to fuel explosive growth in 2021. A growing list of nontraditional VC investors allowed startups to raise even more capital and resulted in the emergence of hybrid funds. Hybrid funds ... READ MORE >
In booming year, venture capital shows no signs of slowing
The venture capital ecosystem is stronger than ever and shows no signs of slowing down, data through the third quarter of the year shows. As of Sept. 30, global VC funding for the year was at $437.7 billion, 158% higher than 2020’s calendar total, per CB Insights. In the United States alone, $82.8 ... READ MORE >
5 things to know in life sciences: Week of October 11
Even in normal times, being the head of a major agency like the U.S. Food and Drug Administration would be challenging. These are far from normal times, so challenges will likely be even greater for the person expected to be nominated by President Biden. This week we also look at preparing for a pandemic ... READ MORE >
Private equity and venture capital stay resilient in the EU and UK
After a year of upheaval, private equity and venture capital dealmaking ended last year on a strong note in the European Union and the U.K., and that momentum is poised to continue. Consider where the industry stood at the beginning of 2020. After the Conservative Party’s decisive victory in late ... READ MORE >
CHART OF THE DAY: Venture capital investment in health tech on track for record year
North American investment in venture capital-backed health technology and digital health companies hit a record through the first 10 months of the year, outpacing all of 2019 with two months to go. The total venture capital raised by health tech so far this year reached $12.2 billion, compared with $10.7 ... READ MORE >
Venture capital tech investments show strength in first half of 2019
For cash-intensive technology companies, access to capital is frequently required to sustain operations and quickly achieve scale. Venture capital firms invested over $30 billion in tech startups in the second quarter of 2019, according to data from Pitchbook, putting total investment on pace to eclipse ... READ MORE >
Biotech needs cash in hesitant market
Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. The analysis suggests that over 100 biotech companies, including makers of oncology therapies and treatments ... READ MORE >